Table:
begin	end	state
1	28	cytoplasmic
29	50	transmembrane
51	55	non-cytoplasmic
56	76	transmembrane
77	103	cytoplasmic
104	128	transmembrane
129	134	non-cytoplasmic
135	156	transmembrane
157	164	cytoplasmic
165	187	transmembrane
188	215	non-cytoplasmic
216	239	transmembrane
240	259	cytoplasmic
260	279	transmembrane
280	298	non-cytoplasmic
299	321	transmembrane
322	346	cytoplasmic
347	369	transmembrane
370	374	non-cytoplasmic
375	399	transmembrane
400	417	cytoplasmic
418	439	transmembrane
440	444	non-cytoplasmic
445	464	transmembrane
465	481	cytoplasmic

Input:
>WP_050461858.1 NCBI__GCF_001189915.1:WP_050461858.1
MHDPTQQFQKIIERERGLQRSLTPGQMSMIAIGGAIGTGLFLGSGFAIGFAGPSVLLSYA
IGAVIAIVLMGCLAEMTVAHPTSGSFGAYAEHYISPWAGFMVRYAYWACIVLAVGTEVTA
IALYMKYWFPAVPGWFWIASFSAALVLINAFSVKVFGAVEYWFSLIKIAAIVGFILLGAY
IVFVAPASLANVGGTAQLAGFHHYVEHGGFFPHGAWGMWVAVIIAIFSYLSIEMIAVAAG
EAKDPETAVTSAFRSTVVRLVLFYLLTLALMLAIVPWTAASHDRSPFVMVMEAINTPGAA
GVINFVVLVAALSSMNSQLYITTRMMFSLSRGGYAPQRLGQVNRRGVPLAALLLSTVGIA
LAVLLSVVYPDASFTIMMAIAMFGALFTWMMIFVTHYFFRRHWNRHGKIPLRFRMIGFPV
LTLLGAGLMLAIMTTTLFVAEFRMTLIFGVPFLILLSLAYFFWYGRRASAPVRDTASKLS
S

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server